Clinical Trials for Pazopanib

2 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TherapeuticVICCGI1250
04/09/2013
A Phase I/II Study of the Combination of Temozolomide and Pazopanib in Advanced Pancreatic Neuroendocrine Tumors (PNET)
TherapeuticVICCURO1088
08/15/2011
A Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Pazopanib as Adjuvant Therapy for Subjects with Localized or Locally Advanced RCC Following Nephrectomy

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.